Product News - Winter 2025 Edition
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing.
16 December 2025Hot Topics
From passive polymers to active platforms: the nanotech evolution of hydrogels
Nanotechnology has unlocked a new generation of hydrogels that can be tuned for specific clinical demands. From degradation kinetics to drug release and mechanical resilience, nanoscale control is transforming hydrogels from passive wound dressings into active, minimally invasive platforms for joint restoration, tissue regeneration and targeted therapeutics
16 December 2025
Making sense of your scientific archive: how RAG helps biotechs do more with less
How is retrieval-augmented generation aiding smaller biotechs in collating and utilising disparate data systems?
16 December 2025
Semantic layering: the technology reshaping pharma data architecture
How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?
16 December 2025
Tablet density uniformity
SPOTLIGHT: Bill Supplee at Natoli Engineering discusses the best ways to ensure tablet density uniformity in pharma products
30 September 2025
Delivering precision at every stage: integrated API and sterile drug product services
SPOTLIGHT: How CARBOGEN AMCIS supports complex molecules and challenging formulations from early development to commercialisation
30 September 2025Product Profile
Product News – Autumn Edition
IPT highlights some of the most recent exciting advancements in pharmaceutical manufacturing
Product Profile, 30 September 2025
Natoli Engineering Introduces EZ Level Feeder Base Leveling System
9 May 2025 -- Missouri, US -- Natoli Engineering, the global leader in tablet compression tooling, is unveiling the EZ Level Feeder Base Leveling System, Part Number SU 2970. This innovative design eliminates long setup times, enhances accuracy and minimizes formulation loss, and increases production time. You will no longer need to settle for “close enough” or “good enough” when using this solution that is built with precision in mind.
Product Profile, 8 May 2025
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
Product Profile, 21 April 2025
Central Research Laboratories: Single-Use Gamma Bags for Biopharma and Life Sciences Applications
25 March 2025 -- Minnesota, US -- Central Research Laboratories (CRL), a global leader in the remote-handling industry, is launching Single-Use Gamma Bags that have been designed to undergo gamma-sterilization procedures. CRL Single-Use Gamma Bags are an addition to the company’s Single-Use Beta Bag product line, which also includes the recently launched Single-Use Double Bags.
Product Profile, 25 March 2025
PR No2 enables quick and easy IR detection
A second edition of the LASER COMPONENTS Pyroelectric Receiver series is now available!
Product Profile, 11 March 2025Press Releases
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026
13 April 2026 -- California, US -- At the Experimental Nuclear Magnetic Resonance Conference (ENC), Bruker Corporation today announced new NMR products and workflow solutions designed to expand performance, sensitivity, and automation across research and applied NMR.
Press Releases, 12 April 2026
Meet CAS Newton: Agentic AI built for science
8 April 2026 -- Ohio, US -- CAS, a division of the American Chemical Society, today announced the launch of CAS NewtonSM, science-smart agentic AI built specifically for scientific discovery. CAS Newton is grounded in published scientific knowledge curated by CAS scientists, drawing on more than 150 years of literature within the CAS Content CollectionTM to ensure accuracy and scientific rigor.
Press Releases, 7 April 2026
Generare raises €20M after generating more novel high quality molecules in 2025 than rest of field
2 April 2026 -- Paris, France -- Generare – the techbio company generating novel, high-quality molecular data for drug development by decoding what life wrote – has raised €20M in Series A funding co-led by Alven and Daphni with participation from all existing investors, including Galion.exe, Teampact Ventures and VIVES Partners.
Press Releases, 1 April 2026
Purdue University accelerates rare disease drug discovery with the WELLJET dispenser stacker
31 March 2026 -- Zizers, Switzerland -- Scientists at Purdue University are using the WELLJET dispenser stacker from INTEGRA Biosciences to increase the speed, consistency and scale of drug screening for rare and neglected parasitic diseases. Integrating automated liquid handling into their workflows has allowed the research team to standardize complex screening assays, improve reproducibility and significantly increase throughput.
Press Releases, 30 March 2026
Semarion secures $3.8million to scale next-generation cell assay tech and accelerate pharma adoption
31 March 2026 -- Cambridge, UK -- Semarion, a University of Cambridge spin-out company from the Cavendish Laboratory combining materials engineering and cell biology to tackle unmet drug screening needs, today announced it has raised $3.8 million USD (£2.9 million GBP).
Press Releases, 30 March 2026Digital
The digital symmetry of virtual pharma: architecting orchestration in an age of fragmentation
How are digital innovations offering a new way of working for contract development and manufacturing organisations?
Digital, 12 April 2026
From AI tools to AI ecosystems: why lab sciences companies are rethinking partnership models
How are deliberately structured artificial intelligence ecosystems integrating the tools scientists already rely on, enabling innovation while preserving provenance, governance and confidence across the drug discovery and development life cycle?
Digital, 12 April 2026
How AI&ML are changing the landscape of pharma technology
From target identification and molecular design to process optimisation and quality control, artificial intelligence and machine learning are being positioned as transformative enablers across the pharma landscape. However, as adoption accelerates, it is becoming clear that the impact of these technologies is not determined solely by model sophistication or computational power. Rather, their effectiveness is fundamentally constrained by the availability, quality and structure
Digital, 12 April 2026
The new risk equation: balancing safety, speed and innovation in digital pharma
How can pharma companies improve their digital systems while maintaining regulatory compliance, and ensure the two teams work together cohesively?
Digital, 16 December 2025Making sense of your scientific archive: how RAG helps biotechs do more with less
How is retrieval-augmented generation aiding smaller biotechs in collating and utilising disparate data systems?
Digital, 16 December 2025Manufacturing
Advanced contamination detection systems in GMP manufacturing
Miriam Krechlok from Mettler-Toledo Product Inspection speaks to IPT about advanced contamination detection systems and how these are utilised in pharma manufacturing to ensure seamless and good manufacturing practice-compliant products
Communication breakdown: why soft skills are more important than ever in life sciences
How are life sciences organisations embracing new technologies to help develop soft skills, hopefully mitigating issues seen in the pharma manufacturing sector?
The future is gloveless
The future of aseptic pharmaceutical manufacturing is gloveless, but what might sound like a bold vision is already turning into reality today
Rethinking early phase development: how to move quickly without creating downstream risk
Early-phase development has always required urgency. Today, that urgency is shaped by a more complex set of pressures than ever before. Competitive intensity, milestone-driven financing structures and expanding regulatory expectations are redefining how biotech and virtual pharma companies approach the earliest stages of development.
Semantic layering: the technology reshaping pharma data architecture
How is semantic layering technology addressing significant efficiency gaps, creating the infrastructure for more efficient manufacturing operations?
Sustainable and scalable approaches to peptide manufacturing
Process innovations provide opportunities to reduce environmental impact while improving efficiency and product quality
X-ray CT for tablets: a powerful non-destructive tool for tablet characterisation
How is X-ray CT being used to ensure quality in tabletting?
Clone selection as a strategic lever: balancing speed, quality and long-term viability in CLD
In biologics development, clone selection is not just a technical milestone, it’s a strategic decision with far-reaching clinical and commercial implications. How can thoughtful clone selection – integrated with developability and manufacturability assessments – accelerate speed to clinic while safeguarding long-term success?
Advancing complex SM process development using biocatalysis
Biocatalysis is enhancing complex molecule process development. By merging the power of enzymes with chemical synthesis, scientists and manufacturers are addressing long-standing challenges in stereoselectivity, route complexity and sustainability
Delivering precision at every stage: integrated API and sterile drug product services
SPOTLIGHT: How CARBOGEN AMCIS supports complex molecules and challenging formulations from early development to commercialisation
Why advanced contamination detection systems are essential for pharmaceutical manufacturing
What are eight compelling reasons why manufacturers should prioritise the use of advanced contamination detection systems in their operations?
Tablet density uniformity
SPOTLIGHT: Bill Supplee at Natoli Engineering discusses the best ways to ensure tablet density uniformity in pharma products
Pharma manufacturing: cooperation for sustainable change
Sustainability is top of the agenda for many pharmaceutical manufacturing companies. Which role do technology providers and their equipment play in reducing CO2 emissions
Synthetic DNA: breaking the bottleneck in genetic medicine manufacturing
Why is the use of synthetic DNA a better choice for emerging genetic medicines?
Innovative manufacturing techniques for gene therapies
What are some innovative techniques used for manufacturing gene therapies at a commercial scale?
Natoli – data collection tips for R&D presses
Tablet formulation development often uses small R&D tablet presses to optimise both the composition of the formulation and manufacturing process parameters. These types of machines have a wide variety of capabilities and may be either single station or small rotaries.
Lab Design
The rise of integrated, digital-first clinical lab systems: three key advances
What is the value of site-to-lab digitalisation, lab trial management systems, and end-to-end biobanking and specimen life cycle management in improving clinical labs?
Agentic AI systems in life sciences labs
Life sciences labs generate enormous volumes of equipment and environmental data, yet many teams still struggle to translate signals into timely, confident action. Agentic artificial intelligence systems can reason within context, prioritise what matters and recommend next steps, offering a shift from reactive alerting to operational decision support.
Drug discovery’s weakest link? Why synthesis is the critical bottleneck in the age of AI
How is artificial intelligence being utilised in labs to synthesise design and workloads?
Labs that think: how intelligent design is shaping the future of pharma R&D
How are emerging design principles like operational insight, molecular infrastructure and human-centred design reshaping safety, agility and performance across the life sciences landscape?
Advancing fluid management in labs with automated small-volume filling
How can the introduction of automation in fluid management systems improve biopharma manufacturing?
Designing for the next generation of pharma labs
How are modern pharma labs being designed with practicality and connectivity to ensure streamlined processes and happy staff?
Smarter labs, better discovery: how automation is evolving pharma R&D
How is the industry translating the potential of automated technologies into practical, flexible and scalable workflows that address the real-world challenges of modern laboratories, ensuring that innovation delivers measurable scientific and operational gains?
From legacy systems to sample automation: managing a successful transition to high-density cold samp
As the need for ultra-low temperature sample storage rises, many labs are stuck expanding outdated ‘freezer farms’ to meet demand. High-density automated cold storage offers a smarter, more efficient solution, but reaping the benefits depends on more than the technology itself – it requires thoughtful change management. How can companies approach change management to drive lasting adoption and maximise the value of automation?
Smart resource strategy: optimising lab assets in pharma
In an era of cost-conscious innovation, including tighter budgets, talent shortages and escalating regulatory demands, life sciences labs are under pressure to improve performance while managing budgets more wisely. By focusing on equipment utilisation and asset intelligence, labs can reduce downtime, avoid unnecessary purchases, optimise maintenance intervals and scale smarter – all without compromising quality or compliance
Robotic automation in the pharma lab
IPT talks to Roya Amini-Naieni at Trilobio about robotic automation in pharma research, the different applications of soft-and hardware, and how the field is likely to develop over the next five years
Automated labs: the future of drug R&D
IPT talks to David Fuller at Artificial Inc about how automated labs are revolutionising the pharma R&D space by connecting disparate systems, easing the burden of manual tasks on workers, and speeding up time-to-market with tools such as artificial intelligence
Rapid microbiological monitoring: transforming environmental monitoring in pharma manufacturing
Ensuring a manufacturing environment stays clear of bacteria and fungi is of utmost importance, especially when it comes to pharmaceuticals. How can this highly specialised monitoring be achieved in a fast, cost-effective manner?
One cannot leverage AI without a connected laboratory
A connected laboratory, where systems and devices communicate seamlessly, is the foundation to unlock AI’s full capabilities
The journey to full automation – for labs of all sizes
With the lab of the future becoming increasingly automated, how will this change workflows and how can the industry prepare for this?
Bridging the gap: Integrating legacy equipment for modular production
The pharmaceutical sector is characterised by intricate processes, stringent regulations and a constant demand for innovation. However, the industry's digital transformation is hindered by the prevalence of legacy machinery, which often poses compatibility challenges when deploying new technology. COPA-DATA explains the method of standardisation to remove the barriers of integration of legacy equipment in labs and production lines
Lab automation: the future of life sciences
'Increasing economic challenges like market vitality, product diversification and cost pressure lead to the need for faster process design' − and that is not to mention the shorter innovation cycles and increasing demand for small batch production. The module type package suite from COPA-DATA meets these needs
Discovery and Development
Designing genetic control: synthetic promoters powering modern therapeutics and biomanufacturing
How is the synthetic design of genetic elements, such as promoters for cell and gene therapies and biologics, improving development and manufacturing?
Discovery and Development, 12 April 2026
Unveiling the function with multi-omics
As scientists continue to explore the vast web of life’s molecular setups, it has become increasingly clear that a singular approach, focusing narrowly on genomics, transcriptomics or proteomics, can no longer encompass the full picture of cellular biology. The integration of multi-omics has emerged as a transformative methodology, combining the study of DNA, RNA and protein layers along with metabolites to illuminate the complexities of life at an unprecedented depth.
Discovery and Development, 12 April 2026
Closing the actionability gap: spatial cell sorting advances drug discovery & translational research
Mapping disease cells in tissue is essential, but extracting and analysing them is what advances drug discovery. Spatial cell sorting enables physical isolation of individual cells for comprehensive multi-omics profiling – bridging the gap between tissue visualisation and functional validation
Discovery and Development, 16 December 2025From passive polymers to active platforms: the nanotech evolution of hydrogels
Nanotechnology has unlocked a new generation of hydrogels that can be tuned for specific clinical demands. From degradation kinetics to drug release and mechanical resilience, nanoscale control is transforming hydrogels from passive wound dressings into active, minimally invasive platforms for joint restoration, tissue regeneration and targeted therapeutics
Discovery and Development, 16 December 2025
ssDNA: a novel approach to overcome efficacy and immunogenicity challenges in genetic medicines
What is single-stranded DNA and why is it a viable viral vector alternative?
Discovery and Development, 30 September 2025Imaging and Sensing
Seeing what matters: how pH-responsive internalisation assays are reframing MoA in pharma
As targeted modalities proliferate, the ability to quantify ligand, antibody and receptor trafficking into acidic compartments at scale and in near real time is giving teams a far more direct read on drug activity. pH-responsive imaging and sensing approaches are unlocking higher throughput and more physiologically relevant internalisation readouts that bridge discovery, screening and translational workflows, helping to close the long-standing gap between beautiful microscopy
Imaging & Sensing, 12 April 2026
From mouse to medicine: the future of NIR-II FGS
As near-infrared imaging advances beyond the NIR-I window, a new generation of NIR-II fluorescent probes is redefining intraoperative visualisation. With improved tissue penetration, reduced scattering and enhanced signal-to-background ratios, these next-generation agents are expanding in vivo applications and opening new perspectives for precision surgery
Imaging & Sensing, 12 April 2026
How imaging flow cytometry is transforming cell and protein therapy
Advancements in imaging flow cytometry have improved the detection of particles in pharmaceutical formulations and helped provide insights into how these protein-based therapeutics work
Imaging & Sensing, 16 December 2025
Lessons learned from sequencing: a smart beginning for meaningful results
Massive sequencing, or next-generation sequencing, has opened the door to the fascinating world of genetics, and the secret on how to use this powerful tool most effectively hinges on the starting point: the sample
Imaging & Sensing, 30 September 2025
Transforming R&D workflows with automated super-resolution microscopy
What is super-resolution microscopy and how is it accelerating progress across the imaging sector?
Imaging & Sensing, 30 September 2025
Analytics for a new therapeutic era: meeting the demands of modern biologics
As novel biologics reshape the therapeutic landscape, more advanced analytics are essential. Single-particle technologies can help fill this gap, delivering faster, clearer insights and supporting the next generation of advanced therapies
Imaging & Sensing, 30 September 2025Conferences and Events
Anglonordic Life Science Conference 2026
11 February 2026 -- London, UK -- Over 350 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, will get together in London on 23rd April, 2026 for the 22nd Annual Anglonordic Life Science Conference
Conferences and Events , 11 February 2026
BIO-Europe 2025
10 July 2025 -- Vienna, Austria -- BIO-Europe, Europe's premier biopharma partnering event, is heading to Vienna, Austria on November 3-5, 2025, followed by Digital Partnering on November 11-12.
Conferences and Events , 9 July 2025
Two Weeks to Go - LBS 2025 Spotlights Industry Pioneers, Disruptive Tech, Emerging Innovators
2 June 2025 — London, UK — In just two weeks, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science, transformative innovation, and forward-thinking leadership.
Conferences and Events , 1 June 2025
Attend Europe’s leading vaccine event!
World Vaccine Congress Europe will host 2500+ attendees, 280 speakers, 150 exhibitors and start-ups over the course of 4 days. With a multitude of tracks, the congress will cover everything vaccine related from start-to-finish from 13-16 October 2025.
Conferences and Events , 26 May 2025
Asia Bio Partnering Forum 2025
Join global biotech and pharma leaders in Singapore, September 9–10, 2025, for the third edition of Asia Bio Partnering Forum.
Conferences and Events , 22 May 2025IPT TV
Inside the 2024 American Biomanufacturing Summit
Inside the 2024 American Biomanufacturing Summit
IPT TV, 3 June 2025
Visitor Registration at the London Biotechnology Show 2025 is Live!
Join the UK’s leading biotechnology event to explore groundbreaking biotech innovations, connect with global healthcare leaders, and discover the future of life sciences for 𝐅𝐑𝐄𝐄.
IPT TV, 21 April 2025
⭐We're proud to be a BioFIT 2024 partner!
Come and join us for the 13th edition of BioFIT, on December 3rd & 4th, 2024 in Lille and digital meetings days on December 11th & 12th, 2024!
IPT TV, 9 October 2024
LSX Nordic Congress 2024
Showcasing innovation, accelerating investment and facilitating partnering for life science leaders in Northern Europe.
IPT TV, 8 September 2024
TIDES Europe: Oligonucleotide & Peptide Therapeutics
Accelerate Your Therapeutics to Market: Expedite R&D, Improve CMC Efficiency & Build New Partnerships Join the industry’s leading event in Europe and access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market.
IPT TV, 4 September 2024
Innovations in Pharmaceutical Technology (IPT)
IPT provides a platform for cutting-edge ideas, concepts, and developments shaping the future of pharmaceutical R&D.